| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |